scispace - formally typeset
Journal ArticleDOI

Hughes syndrome (the antiphospholipid syndrome): a disease of our time.

Graham R. V. Hughes
- 01 Apr 2011 - 
- Vol. 19, Iss: 2, pp 69-73
TLDR
There are indications that the primary antiphospholipid syndrome will turn out to be more common than lupus, though this could still be a reflection of referral practice.
Abstract
A pro-thrombotic condition was described in 1983 which was characterised by the presence of circulating antiphospholipid antibodies, as well as peripheral thrombosis (e.g. DVT), a tendency to internal organ involvement, repeated miscarriage, and, occasionally, thrombocytopenia (aPL) (Hughes, Br Med J 287:1088–1089, 1983). Previously, there had been a number of observations, mainly in patients with lupus having “false positive” tests for syphilis, miscarriage and circulating lupus anticoagulants. The description in 1983 had three notable features (a) a detailed comprehensive clinical picture of the syndrome; (b) this description differed from other coagulopathies in showing a propensity for arterial thrombosis (e.g. stroke and heart attack); and (c) this was a syndrome quite independent from lupus. There are indications that the primary antiphospholipid syndrome will turn out to be more common than lupus, though this could still be a reflection of referral practice.

read more

Citations
More filters
Journal ArticleDOI

Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art.

TL;DR: In this article, the current state of immunological risk factors in RPL in international guidelines of the European Society of Reproduction and Embryology (ESHRE), American Society Of Reproductive Medicine (ASRM), German/Austrian/Swiss Society of Obstetrics and Gynecology (DGGG/OEGGG/SGGG) and the Royal College of Obstetricians and gynecologists (RCOG) are evaluated.
Journal ArticleDOI

Immune profiling in patients with recurrent miscarriage.

TL;DR: It is suggested that the immunological diagnosis should be implemented only in well-designed clinical trials in specialized centers to establish a standardized immunological work-up in RM patients and the exact mechanisms of feto-maternal tolerance have not yet been determined.
Journal ArticleDOI

Reflections on Lupus 2013: butterflies, wolves and prophecies

TL;DR: This overview summarizes some of the origins of the First International Congress held in Calgary, Canada in 1986, predictions offered by past Congress Presidents, and a perspective on the trends in autoantibody testing, which remains one of the key approaches to the early and accurate diagnosis of SLE.
Journal ArticleDOI

Leg ulcers in antiphospholipid syndrome secondary to systemic lupus erythematosus treated with intravenous immunoglobulin.

TL;DR: This case illustrates a rare cause of leg ulcers and documents that IVIg may be an effective adjuvant treatment in the management of selected patients with antiphospholipid syndrome when conventional strategies using subcutaneous heparin and low-dose aspirin are insufficient.
References
More filters
Journal ArticleDOI

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

TL;DR: A new solid-phase radioimmunoassay for the detection of anticardiolipin antibodies is 200-400 times more sensitive than the precipitation method used in the Venereal Disease Reference Laboratory test and appears to have predictive value for thrombosis in SLE and related disorders.
Journal ArticleDOI

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Graham R. V. Hughes
- 15 Oct 1983 - 
TL;DR: Few diabetics register on the Disabled Persons Register, but those with disabling complications may find it advantageous to do so and to seek the advice of their local disablement resettlement officer.
Journal ArticleDOI

Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study

TL;DR: It is suggested that lupus anticoagulant is a major risk factor for arterial thrombotic events in young women, and the presence of other cardiovascular risk factors increases the risk even further.
Journal ArticleDOI

Seronegative antiphospholipid syndrome

TL;DR: Raised levels of antiphospholipid antibodies (aPL), especially IgG aPL, are associated with the increased thrombotic risk characteristic of the syndrome, however, as always in real clinical practice, there are often discrepancies between antibody levels and clinical disease expression.
Related Papers (5)